Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
There are a few known risk factors for eye cancer, particularly melanoma of the eye (also known as ocular melanoma or intraocular melanoma).
A risk factor is anything that increases your chance of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person¡¯s age or family history, can¡¯t be changed.
But having a known risk factor, or even several risk factors, does not mean that you will get the disease. And many people who get the disease may have few or no known risk factors.
The risk of eye melanoma is higher in people with lighter colored skin (and who sunburn or freckle easily) than in people with darker skin tones.
People with light colored eyes are somewhat more likely to develop melanoma of the eye than are people with darker eye color.
Eye melanomas can occur at any age, but the risk goes up as people get older.
Eye melanoma is slightly more common in men than in women.
People with this inherited condition have many abnormal moles (dysplastic nevi) on their skin. If at least one close relative has had melanoma, this condition is referred to as familial atypical multiple mole and melanoma (FAMMM) syndrome.
People with this syndrome are at increased risk of skin melanoma. They also seem to have a higher risk of developing melanoma of the eye.
This is a rare inherited condition in which family members are at increased risk for eye melanoma, as well as melanoma of the skin, mesothelioma, kidney cancer, and some other cancers.
This condition is caused by an inherited mutation (change) in the BAP1 gene. Cancers linked with this syndrome tend to be aggressive and often appear at younger ages.
Different types of moles (nevi) and pigmented areas in the eye have been linked with an increased risk of eye melanoma. These include choroidal, giant choroidal, and iris nevi, as well as ocular dermal melanocytosis (nevus of Ota).
An eye condition known as primary acquired melanosis (PAM), where the melanocytes in the eye grow too much, is a risk factor for conjunctival melanoma.
Welders, who can be exposed to intense ultraviolet (UV) light when they work, have been found to have a higher risk of eye melanoma.
Sun exposure: Too much exposure to UV light from sunlight (or sunlamps) is a known risk factor for melanoma of the skin. It has also been suggested as a possible risk factor for melanoma of the eye, but studies so far have shown mixed results. More research is needed to answer this question, but if there is an increased risk, it is likely to be small.
Skin melanoma: Some people with eye melanoma have a history of melanoma of the skin, but it¡¯s not clear if having skin melanoma increases your risk of eye melanoma.
Developed by the ÁñÁ«ÊÓÆµ medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Grisanti S, Tura A. Uveal Melanoma. In Scott JF, Gerstenblith MR, eds. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018. Accessed at https://www.ncbi.nlm.nih.gov/books/NBK506988/ on April 8, 2025.
Harbour JW, Shih HA. Initial management of uveal and conjunctival melanomas. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/initial-management-of-uveal-and-conjunctival-melanomas on April 8, 2025.
Houghton O, Gordon K. Chapter 64: Ocular Tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff¡¯s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 118: Welding, Molybdenum Trioxide, and Indium Tin Oxide. 2018. Accessed at https://publications.iarc.fr/569 on April 8, 2025.
Masoomian B, Shields JA, Shields CL. Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma. J Curr Ophthalmol. 2018;30(2):102-109.
Mahendraraj K, Lau CS, Lee I, Chamberlain RS. Trends in incidence, survival, and management of uveal melanoma: A population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973¨C2012). Clinical Ophthalmology (Auckland, NZ). 2016;10:2113-2119.
National Cancer Institute. Intraocular (Uveal) Melanoma Treatment (PDQ?)¨CHealth Professional Version. 2024. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq on April 8, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Uveal. V.1.2025. Accessed at https://www.nccn.org on April 8, 2025.
Sullivan RJ, Shoushtari AN. The molecular biology of melanoma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/the-molecular-biology-of-melanoma on April 8, 2025.
Last Revised: May 5, 2025
ÁñÁ«ÊÓÆµ medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the ÁñÁ«ÊÓÆµ.